Steve Almond

Steve Almond possesses extensive experience in statistical analytics and biostatistics, currently serving as the Head of Oncology Statistical Analytics for North America at Bayer since August 2015. Prior to this role, Steve held various positions at GSK, including Principal Statistician and Senior Statistician, contributing significantly to biostatistical analyses. Steve's career began with valuable roles at Research In Motion (BlackBerry) and the University of Waterloo, where involvement included system administration and consulting for statistical projects. An academic background from the University of Waterloo includes a Bachelor's degree in Applied Mathematics and Statistics and a Master's degree in Statistics with a focus on Biostatistics.